Pfizer is in talks with India and has pledged to make its COVID-19 vaccine available for deployment in the country, the US doctor was quoted as saying by Reuters. The company said it offered India a non-profit price for its vaccine for the government’s immunization program.
Last week, the Indian government said it would quickly pursue emergency approvals for COVID-19 vaccines manufactured abroad, a move that would exempt companies from conducting “binding” studies for their vaccines.
Meanwhile, Johnson & Johnson said it is trying to conduct a local clinical trial in India for its single-dose COVID-19 vaccine.
India is facing a massive increase in covid cases, which has severely strained its health system and caused a lack of oxygen and medicines.
India today recorded the highest daily number of 314,835 COVID-19 infections in a single day.
According to Reuters, the previous increase in cases was recorded by the United States, which registered 297,430 new cases in one day in January, although its number fell sharply.
The total number of cases in India is now 15.93 million, while deaths have increased by 2,104 in the last 24 hours, to a total of 184,657, according to the latest data from the Ministry of Health.
The Indian government will open its vaccination initiative on May 1 to cover those over 18 years of age.
This week, Prime Minister Narendra Modi called on state governments to use blockages as a last resort. He urged people to stay inside and said the government was working to increase the supply of oxygen and vaccines.
In the meantime, Pfizer has announced that it will provide another 100 million doses of its COVID-19 vaccine to the 27 Member States of the European Union (EU) in 2021. This announcement is the result of the European Commission’s (EC) decision to exercise the option. to purchase a further 100 million doses under its Extended Advanced Procurement Agreement signed on 17 February 2021. This brings the total number of doses to be delivered to the EU to 600 million.